Rti (b)(4) conducted a batch documentation review for serial id (b)(4) manufactured from lot pd18100001.No departures from standard operating procedures were noted during the records re-review that would negatively impact the manufacturing of porcine dermis xenografts from the lot.Manufacturing records review indicated that serial id (b)(4) met all acceptance / inspection criteria prior to distribution.To date, rti germany has manufactured and distributed 51 fortiva dermis grafts from the lot without related complaints.In general, problems in wound healing can have many causes, e.G.Injuries, surgeries, failure of blood supply to the site, infection or radiation therapy.The patient was a current smoker which may have influenced blood flow and capillary vessel lumen in the skin at the implantation site.Further, the surgery, silicone implants were placed as well on both sides that were considered further confounding factors.It is more plausible that the patient's adverse event was associated with a source or event extrinsic to the xenograft implants.
|
Rti surgical, inc.And tutogen medical (b)(4), a wholly subsidiary of rti surgical, received a complaint as part of the fortiva appear trial.The reported complaint indicated on (b)(6) 2020, the patient underwent a bilateral breast reconstruction with implantation of two fortiva grafts and placement of two expanders.The patient had 11 lymph nodes removed on the right side and 9 lymph nodes removed on the left.On (b)(6) 2020, the patient experienced delayed wound healing.The patient was hospitalized (b)(6) 2020.The issue resolved on (b)(6) 2020.The cutaneous necrosis from the vertical scar was conservatively treated; the seam dehiscence and the edges of the wound were refreshed.The information in this also associated with mfr report #: 3002924436-2021-00007.
|